These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21654135)

  • 1. Unilateral common peroneal nerve palsy following renal transplantation: a case report of tacrolimus neurotoxicity.
    Jain A; Mathew PJ; Modi M; Mangal K
    J Postgrad Med; 2011; 57(2):126-8. PubMed ID: 21654135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An idiosyncratic reaction of unilateral common peroneal nerve palsy associated with below desired therapeutic range of tacrolimus level in a patient postheart transplantation.
    Srivastava A; Abhisek PA; Pradhan SS
    Indian J Pharmacol; 2022; 54(6):459-461. PubMed ID: 36722558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo tacrolimus- associated hemolytic uremic syndrome after renal transplantation - case report.
    Neto P; Lopes K; Macário F; Alves R; Mota A; Campos M
    Nefrologia; 2013 Jan; 33(1):152-4. PubMed ID: 23364650
    [No Abstract]   [Full Text] [Related]  

  • 4. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.
    Venneti S; Moss HE; Levin MH; Vagefi MR; Brozena SC; Pruitt AA; Mourelatos Z; Trojanowski JQ; Galetta SL; Balcer LJ
    J Neurol Sci; 2011 Feb; 301(1-2):112-5. PubMed ID: 21112060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports.
    Bhagavati S; Maccabee P; Muntean E; Sumrani NB
    Transplant Proc; 2007 Dec; 39(10):3465-7. PubMed ID: 18089409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic ketoacidosis following development of de novo diabetes in renal transplant recipient associated with tacrolimus.
    Ersoy A; Ersoy C; Tekce H; Yavascaoglu I; Dilek K
    Transplant Proc; 2004 Jun; 36(5):1407-10. PubMed ID: 15251345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus associated to posterior reversible atypical encephalopathy syndrome and brain haemorrhage in renal transplant recipient.
    Cadavid-Aljure D; Caicedo-Paredes A; Meza JC; Granados-Sánchez AM; Posada-Chávez JG; Mesa-Ramírez L; Schweineberg-López J
    Nefrologia; 2012; 32(6):861-3. PubMed ID: 23169384
    [No Abstract]   [Full Text] [Related]  

  • 8. Tacrolimus-induced encephalopathy and polyneuropathy in a renal transplant recipient.
    Wu G; Weng FL; Balaraman V
    BMJ Case Rep; 2013 Dec; 2013():. PubMed ID: 24311415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gangliocytoma Presenting With Tacrolimus Neurotoxicity in a Renal Transplant Recipient: Case Report.
    Alagoz S; Gulcicek S; Oruc M; Trabulus S; Seyahi N
    Transplant Proc; 2016 Nov; 48(9):3142-3144. PubMed ID: 27932167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catatonia Due to Tacrolimus Toxicity 16 Years After Renal Transplantation: Case Report and Literature Review.
    Sikavi D; McMahon J; Fromson JA
    J Psychiatr Pract; 2019 Nov; 25(6):481-484. PubMed ID: 31821227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R; Galeano C; Fernández-Rodriguez A; Jiménez-Alvaro S; Teruel JL; Rivera M; Burgos FJ; Quereda C
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tacrolimus-induced severe cholestasis complicating renal transplantation.
    Yadav DK; Gera DN; Gumber MR; Kute VB; Patel MP; Vanikar AV; Trivedi HL
    Ren Fail; 2013; 35(5):735-7. PubMed ID: 23560366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus-induced neutropenia in renal transplant recipients.
    De Rycke A; Dierickx D; Kuypers DR
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):690-4. PubMed ID: 21258040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients.
    Chang HR; Lin CC; Lian JD
    Transplant Proc; 2007 Dec; 39(10):3135-41. PubMed ID: 18089339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immediate conversion from tacrolimus to cyclosporine in the treatment of posttransplantation diabetes mellitus.
    Oberholzer J; Thielke J; Hatipoglu B; Testa G; Sankary HN; Benedetti E
    Transplant Proc; 2005 Mar; 37(2):999-1000. PubMed ID: 15848603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation.
    Vincenti F; Rostaing L;
    Contemp Clin Trials; 2005 Feb; 26(1):17-24. PubMed ID: 15837449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipidaemia among renal transplant recipients: cyclosporine versus tacrolimus.
    Fazal MA; Idrees MK; Akhtar SF
    J Pak Med Assoc; 2014 May; 64(5):496-9. PubMed ID: 25272531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever of unknown origin in renal transplant patients with tacrolimus.
    Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
    Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe neurotoxicity in tacrolimus-treated living kidney transplantation in two cases.
    Veroux P; Veroux M; Puliatti C; Valvo M; Macarone M; Cappello D
    Urol Int; 2003; 71(4):433-4. PubMed ID: 14646448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.